FLOGEN Technologies Inc.
Corporate brand
UnclaimedCanadian sustainable high-tech applied research institute founded in 1996, specializing in metallurgy, chemistry, biochemistry, environmental protection, and industrial process optimization.
Last updated September 26, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
FLOGEN Technologies Inc. is a Canadian sustainable high-technology applied research and development company founded in 1996 and headquartered in Montreal, Canada. It operates as a research institute and consulting organization with a presence in more than fifteen countries and projects delivered in over forty countries across six continents. The company's mission is dedicated to developing new sustainable technologies and transforming existing technologies into sustainable ones, working at the intersection of science and sustainability. FLOGEN operates in several core fields: metals extraction and processing, chemistry, biochemistry, and environmental protection. Its activity is carried out in two parallel tracks: transforming existing technologies into sustainable ones and developing new sustainable technologies through science and technology innovation. The company specializes in process optimization, automation, decision-support systems, metallurgical and chemical process innovation, environmental technologies, and interdisciplinary scientific collaboration. It positions itself at the forefront of Industrial Revolution 4.0, offering next-generation digital design-decision making-control-optimization and automation systems used to design and develop sustainable technologies while simultaneously protecting the environment, decreasing cost, and increasing productivity, efficiency, and profitability. The biochemistry department conducts cutting-edge research in RNA biology in neurosciences, micro RNAs, and translational control in cancer. Specific research areas include how translational control via 4E-BP proteins and eIF4E affect synaptic plasticity, memory, and learning capability in the central and peripheral nervous system, with goals to produce medications treating memory loss and Parkinson's disease. The company also examines CDK 5 in neurons and potential therapeutics targeting CDK 5 for neurodegenerative diseases, as well as CDK 4/6 inhibitors and eIF4E phosphorylation in cancer. FLOGEN has published over 200 articles in metallurgy, chemistry, and environmental protection, and has organized 120 conferences. The company is led by Dr. Florian Kongoli, who serves as President and CEO. Dr. Kongoli is a Guest Member of the European Academy of Sciences, Honorary Member of the Lorraine Academy of Sciences, Presidium Member of the Euro Mediterranean Academy of Arts and Sciences, Honorary Citizen of Rio de Janeiro, Brazil, and recipient of the Gold Medal of the City of Nancy, France. FLOGEN maintains a formal Code of Ethics and Business Conduct and operates in accordance with applicable national and international regulations, with a governance framework grounded in transparency, accountability, and professional integrity.
History
FLOGEN Technologies Inc. was founded in 1996 as a Canadian sustainable high-technology applied research and development company. From its headquarters in Canada, the organization grew into an international research institute with offices established in more than fifteen countries and projects carried out in over forty countries across six continents: North America, Europe, Australia, Asia, and South America. The company was built on the principle of sustainability, with scientific research and development at the foundation of its products and services. Its early work focused on metals extraction and processing, chemistry, biochemistry, and environmental protection. Over time, FLOGEN developed two parallel tracks of activity: transforming existing technologies into sustainable ones and developing new sustainable technologies through science and technology innovation. FLOGEN has published over 200 articles in the distinct areas of metallurgy, chemistry, and environmental protection, and has organized 120 conferences. The company has also been involved in 25 years of operation, 200 projects, 10 industries, 40 reactors, 45 countries, and 6 continents, according to its official website. Under the leadership of Dr. Florian Kongoli, FLOGEN has positioned itself at the forefront of Industrial Revolution 4.0, developing next-generation digital design-decision making-control-optimization and automation systems. These systems are used to design and develop new sustainable technologies and transform existing ones by simultaneously protecting the environment, decreasing cost, and increasing productivity, efficiency, and profitability. The company's biochemistry department has conducted cutting-edge research in RNA biology in neurosciences, micro RNAs, and translational control in cancer. Research areas include how translational control via 4E-BP proteins and eIF4E affect synaptic plasticity, memory, and learning capability in the central and peripheral nervous system, with the goal of producing medications to treat memory loss and Parkinson's disease. FLOGEN also examines CDK 5 in neurons and potential therapeutics targeting CDK 5 to help stem the progress of neurodegenerative diseases, as well as the ATF4 transcriptional factor and its impact on memory via the integrated stress response. In cancer research, the company advances studies on CDK 4/6 inhibitors and potential new therapeutics targeting eIF4E phosphorylation and the integrated stress response. FLOGEN maintains a formal Code of Ethics and Business Conduct applicable to its directors, officers, employees, consultants, contractors, and representatives. The Code establishes standards of lawful conduct, professional responsibility, and ethical behavior in all business activities. The organization operates in accordance with applicable national and international regulations and maintains a governance framework grounded in transparency, accountability, and professional integrity. As of its corporate governance statement, FLOGEN Technologies Inc. is a Canadian-based company with a presence in more than fifteen countries and projects delivered in over forty countries across six continents. The company continues to grow its international presence daily, with customer satisfaction as its number one priority.
- 1996
FLOGEN Technologies Inc. founded in Canada.
Established offices in more than 15 countries.
Carried out projects in over 40 countries across six continents.
Published over 200 articles in metallurgy, chemistry, and environmental protection.
Organized 120 conferences.
Products and positioning
A sustainable, high-tech applied research institute at the forefront of Industrial Revolution 4.0, dedicated to transforming existing technologies into sustainable ones and developing new sustainable technologies through science and technology innovation.
Next-generation digital design-decision making-control-optimization & automation systems
Digital systems used to design and develop new sustainable technologies and transform existing ones by simultaneously protecting the environment, decreasing cost, and increasing productivity, efficiency, and profitability.
Sustainable technology transformation services
Services that transform existing industrial processes into more efficient and environmentally responsible systems.
Applied research and development
Research and development in metals extraction and processing, chemistry, biochemistry, and environmental protection.
International scientific summits and conferences
FLOGEN organizes international summits, local events, and conferences.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/flogen-technologies-canada · Editorial policy · How profiles are compiled